Published: 1st July 2001
Christian Medical Fellowship is interdenominational and has as members over 5,000 doctors throughout the United Kingdom and Ireland who are Christians and who desire their professional and personal lives to be governed by the Christian faith as revealed in the Bible. We have members in all branches of the profession and through the International Christian Medical and Dental Association are linked with like-minded colleagues in more than 90 other countries.
We regularly make submissions on a whole range of ethical matters to Governmental and other bodies, and welcome this opportunity to comment on 'genetics and human behaviour: the ethical context'. We are encouraged that the Council is making a special issue of this topic. This Submission has been produced after discussion with members of our Medical Study Group.
We have made other submissions to the Council and other official bodies on genetics issues which are accessible on our website at www.cmf.org.uk/ethics/subs/subs.htm and the committee is welcome to consult these and the enclosed recent CMF File on Genes and Behaviour for more relevant background material.
May we begin by commending the Working Party for their Public Consultation Document which provides an excellent basis for discussion on these vital issues.
Advantages include a greater understanding of mental illness and probably of mental processes in general, and in the long-term the possible development of better treatments for mental illness. The potential disadvantages are well highlighted throughout the consultation document. We would particularly emphasise the risks of commercial and political exploitation of vulnerable groups, the difficulties of regulating research, the dangers of fostering public belief in crude genetic determinism and fuelling unrealistic expectations of 'miracle cures', and the risk of cultivating a reductionist view of humanity.
Yes, because our behavioural and personal traits are very much more integral to our underlying identity, than are our physical features. This means that identifying or probing the underlying genes has an air of dissecting the foundations of the person. Also, psychology is a less exact science: causes tend to be multifactorial, assessment is more subjective, abnormal genetic findings are less predictive of future abnormal behaviour and there is less agreement on definitions and the limits of normality. If it is reported, for example, that 'tall men more often have a prison record than short ones' most people are aware of enough unaffected tall men to take a 'so what' attitude; but that is less likely to occur with a behavioural trait.
Scientific inquiry should be motivated by a desire to benefit individuals suffering mental disorders, and aimed at meeting genuine need rather than public or commercial demand. Given limited resources and funds available for research, priority should be given to research into genetic predispositions for severe mental illness, rather than mildly abnormal character traits. It also needs to be balanced against demand for funding for research into diseases causing serious morbidity and mortality in disciplines other than mental health; regionally, nationally and globally. Absolute bans on lower priority areas of research, however, may prevent serendipitous findings, be difficult to regulate, and may drive research off-shore into locations where responsible oversight is less available.
It should have a positive impact if those who have a genetic predisposition can be reliably identified and subsequently protected from environmental and social conditions which might make it more likely for them to develop behavioural problems. But the concerns of those who see funding for genetics siphoning off funding previously available for social and environmental research are founded in reality and steps need to be taken to avoid this occurring. By its very nature research into behavioural genetics attracts more public and media interest, promises more financial reward, attracts more government prestige and fuels unrealistic expectations more than research into environmental and social conditions causes of disease. There is also a psychological incentive to find 'no-fault' causes for psychopathology, rather than to discover and expose social or environmental causes of behavioural problems which might require changes in social policy or lead persons or parties to apportion blame. Genetic research has so far contributed little to advances in some other fields of medicine such as neonatology and geriatrics, and may be even less effective in developing treatments for behavioural disorders. Also, it is all too clear that the discovery of social and environmental conditions leading to mental disorder does not always lead to mitigation of these conditions.
Better treatment of mental illness, alcoholism, addiction, autism and hyperactivity might result. But seeing the future is not necessarily a blessing if it is a future without hope of effective treatment. If commercial testing is developed with heavy promotional campaigns, and heavy public demand for knowledge of non-pathological traits, a 'horoscope' culture could arise.
Such tests must be regarded a very low priority. First there must be extensive data collection to ascertain the limits and associations of any identified genetically influenced tendencies to the development of a behavioural phenotype. When this has been accomplished it may well be that the relation between genes and behaviour is found to be too complex to make the development of tests for behavioural traits and personality characteristics worthwhile. For pathological conditions such as hyperactivity evidence-based clinical behavioural assessment should be preferred unless or until 'gene tests' with high sensitivity and specificity become available. A misinformed and anxious public could be easily exploited if commercial interests shape priorities. Rather than imposing absolute bans it may be wiser to demand that a certain percentage of all research funding devoted to this area is prioritized to severe mental illness, or by disease category.
No, for a range of reasons:
Many of these are outlined in the document.
Hopefully a greater understanding of mental illness and pathologically deviant behaviours. However, with the difficulty in distinguishing deviant from normal behaviours there must be the possibility of categorisation, medicalisation and possible stigmatisation of 'normal' individuals who are at the outer edges of the normal distribution. Knowing that a disability or abnormality is genetically influenced may provide relief to those troubled that some act or omission of theirs was responsible. However as most situations will be multifactorial this will be less clear-cut.
Yes. It is moral to correct a trait thought to be the result of a genetic abnormality or defect, provided that this can be done safely and effectively. This is putting back to normal an error that has occurred. It is 'restoring the masterpiece'. Enhancement of that trait for a normal individual however is in a different category. We believe that human variation is a given that must be respected, whilst conceding that the distinction between curative and enhancing measures is sometimes blurred. The morality of the action depends on the motive. To enhance body strength by taking anabolic steroids in order to cheat and win at any cost is immoral and most enhancements would have the motive of being more competitive with regard to beauty, intelligence etc. But the issue of enhancement is largely an issue of resource allocation and clinical priority. Medicine is about restoring function and treating illness, not about conformity to an ideal.
If we are talking about enhancement by germline or somatic gene therapy, rather than by the use of gene products (eg. growth hormone) it is qualitatively different in that:
Yes. There is a Christian principle that from those to who much has been given, much will be expected - and vice versa. Human beings are exposed to different genetic and environmental influences and vary in physical and intellectual ability and the degree to which they can be held directly responsible for their actions accordingly varies. However this does not alter the fact that all human beings are responsible to some degree for their actions and behaviour. Behavioural research may help us to understand better the genetic factors which contribute to enhancing or constraining certain behaviours, but we should resist surrendering to that crude genetic determinism that undermines moral responsibility: 'My genes made me do it'.
Discovery of those with possible genetic predispositions to deviant behaviour should be encouraged to behave responsibly. They should not be held blameless or unable to help themselves, neither should they be regarded as an inevitable public danger and therefore be dealt with severely. (XYY karyotype is rarely used in defence or prosecution). Christians believe that all are created in the Image of God and that the freedom to choose between right and wrong is part of the essence of being human. For some with certain genetic make-up such choices may be particularly hard so that extra support and encouragement should be provided. Christians also believe that all are redeemable and that individuals can change their way of life whatever their behavioural characteristics. Numerous examples both ancient and modern could be given.
We are very concerned to ensure that discrimination, stigmatization, stereotyping and scapegoating are not fuelled by research in behavioural genetics, whilst agreeing that current discriminators such as skin colour, education and social class are likely to be as important.
These are difficult to predict at present, but research with genetic screening would suggest that heightened anxiety about the future behaviour may be a factor. Our concerns about discrimination, stigmatization, stereotyping and scapegoating are equally important here.
There could be pressure to use genetic tests in place of evidence-based medical and educational assessments, personality questionnaires etc. We are concerned about the overvaluing of genetic tests and the undervaluing of already proven, and probably ultimately more effective, behaviour assessment measures currently in use. There are also the dangers of vested interests, commercial exploitation and covert manipulation.
No, certainly not at this very hypothetical stage. It is vital that the vulnerable are protected from exploitation.
In the same way that consent for other procedures is obtained, which is currently being reviewed and evaluated. Skilled counselling and correct and full information must be available. Proper counseling is time-intensive and expensive and involves skilled and highly trained personnel. It does not simply involve the imparting of information, but also the provision of support and sharing of responsibility in the decision-making process. Because of commercial considerations it is highly probable that adequate counseling will not be made available and that counselees may receive inadequate information or support, or not understand the consequences of decisions made. Again it is essential that vulnerable individuals are protected from exploitation and coercion.
This is a major issue that needs urgent attention and money as progress is likely to take years rather than months. The basics of genetics as applied to life in the 21st century should be taught at all levels in schools and topics such as this consultation included in citizenship classes. This requires skilled and trained teachers being available to teach it. Most schools are hard-pressed to keep going anyway so money is required if progress is to be made.
The media and internet have a huge responsibility here; and as there are strong commercial pressures to provide material of high entertainment-value, but dubious truth-value, there have to be incentives for accurate presentations of the facts in documentaries, docudramas, interviews and soaps and legal safeguards against misinformation that could fuel misunderstanding and prejudice. The internet carries the danger of unhelpful views having equal exposure and as much opportunity for dissemination as helpful ones. Authoritative sites; such as the BBC or Medical Journal and Official patient-information sites have a huge role to play here.
Yes, particularly if funded by pharmaceutical or similar companies. Codes of practice should include enquiries about the arrangements for publication of results and the matter of who owns the results. The funding agency should have no power to inhibit the publication of adverse or negative results. There should be freedom of access to results, or if not, then careful written agreement as to the reasons for this and occasions when such a ban might be waived.
There should be adequate arrangements for research workers to discuss their work with colleagues or with others particularly if they have ethical concerns about the way the project is developing. Review by ethical committee should occur not only at the start of a project but also later to see where trends are leading. Codes of practice are preferable to regulations but only if there are means whereby they can be monitored and enforced.
Yes. Particularly with regard to:
For mental illness reasonable priority, for non-pathological traits very low priority.
Steven Fouch (CMF Head of Communications) 020 7234 9668
Alistair Thompson on 07970 162 225
Christian Medical Fellowship (CMF) was founded in 1949 and is an interdenominational organisation with over 5,000 doctors, 900medical and nursing students and 300 nurses and midwives as members in all branches of medicine, nursing and midwifery. A registered charity, it is linked to over 100 similar bodies in other countries throughout the world.
CMF exists to unite Christian healthcare professionals to pursue the highest ethical standards in Christian and professional life and to increase faith in Christ and acceptance of his ethical teaching.